dermatology
psoriasis

Real-world data shows long term efficacy of biologics in psoriasis


About one in ten patients with chronic plaque psoriasis can expect to have sustained long term disease control with biologic drugs, experience from a UK dermatology centre suggests. After eight years of follow up, 12% (68) of 560 patients treated with biologics (17 infliximab, 38 etanercept, 239 adalimumab, 266 ustekinumab) showed enduring improvements in PASI ...

Already a member?

Enter your email to keep reading.


OR